Enorama Pharma

Enorama Pharma is a Swedish pharmaceutical company based in Malmö, with a fully owned US subsidiary in Florida. Since 2006, the company has been focusing on the development and manufacturing of consumer-friendly, oral nicotine products such as nicotine white pouches under the brand name NIC-S® and nicotine chewing gum (medicinal). Enorama Pharma AB has been listed on Nasdaq First North Growth Market in Stockholm since 2016. The company's innovative approach to creating oral nicotine products and its presence in both the Swedish and US markets positions it as an attractive investment opportunity for venture capitalists seeking exposure to the pharmaceutical and consumer goods industries. Enorama Pharma's commitment to consumer-friendly products and its listing on a major stock exchange further enhances its appeal to potential investors, making it an intriguing prospect for those looking to capitalize on the growing demand for innovative nicotine delivery systems. As the company continues to expand and develop its product offerings, it presents an exciting opportunity for investment in the evolving landscape of oral nicotine consumption.